[1] Huh WK, Ault KA, Chelmow D, et al. Use of primary hr-human papillomavirus testing for cervical cancer screening: interim clinical guidance[J]. Obstet Gynecol, 2015, 125(2): 330-337.[2] Ostör AG. Natural history of cervical intraepithelial neoplasia: a critical review[J]. Int J Gynecol Pathol, 1993,12(2):186-192.[3] Rodriguez AC, Schiffman M, Herrero R, et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections[J]. J Natl Cancer Inst, 2008,100(7): 513-517.[4] Joseph A, Jordan AS.子宫颈学[M]. 郎景和,译. 山东:山东科学技术出版社, 2009:368.[5] 陈烨. TruScreen宫颈癌筛查系统及液基细胞学检测在宫颈病变筛查中的多中心对比研究[D]. 中山大学学报, 2010. (2016-04-05收稿[1] Huh WK, Ault KA, Chelmow D, et al. Use of primary hr-human papillomavirus testing for cervical cancer screening: interim clinical guidance[J]. Obstet Gynecol, 2015, 125(2): 330-337.[2] Ostör AG. Natural history of cervical intraepithelial neoplasia: a critical review[J]. Int J Gynecol Pathol, 1993,12(2):186-192.[3] Rodriguez AC, Schiffman M, Herrero R, et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections[J]. J Natl Cancer Inst, 2008,100(7): 513-517.[4] Joseph A, Jordan AS.子宫颈学[M]. 郎景和,译. 山东:山东科学技术出版社, 2009:368.[5] 陈烨. TruScreen宫颈癌筛查系统及液基细胞学检测在宫颈病变筛查中的多中心对比研究[D]. 中山大学学报, 2010. (2016-04-05收稿 |